ETC
RPTX

Exchange Traded Concepts’s Repare Therapeutics RPTX Stock Holding History

Exchange Traded Concepts’s Portfolio RPTX Stock Details RPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-50,441
Closed -$66.1K – 1431
2024
Q4 		$66.1K Hold
50,441
– – ﹤0.01% 1199
2024
Q3 		$174K Buy
50,441
+8,809
+21% +$29K ﹤0.01% 1008
2024
Q2 		$137K Sell
41,632
-12,953
-24% -$46.2K ﹤0.01% 916
2024
Q1 		$257K Buy
54,585
+41,000
+302% +$263K 0.01% 854
2023
Q4 		$99.2K Buy
13,585
+3,445
+34% +$19.3K ﹤0.01% 887
2023
Q3 		$122K Sell
10,140
-1,305
-11% -$13.5K ﹤0.01% 836
2023
Q2 		$121K Buy
+11,445
New +$118K ﹤0.01% 907

Other funds holding RPTX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

Exchange Traded Concepts's RPTX Position: Q1 2025 in Review

Exchange Traded Concepts sold out of Repare Therapeutics (RPTX) in Q1 2025, closing a stake of 50,441 shares — an estimated $66.1K sold.

Exchange Traded Concepts first reported a position in RPTX in Q2 2023 and held it in 7 quarters. The position peaked at $257K in Q1 2024. 50 funds tracked by Wall St. Rank hold RPTX as of Q1 2025.

  • Exchange Traded Concepts reported no remaining Repare Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Exchange Traded Concepts sold 50,441 Repare Therapeutics shares in Q1 2025, an estimated $66.1K.
  • Exchange Traded Concepts first reported a position in Repare Therapeutics in Q2 2023 and held it in 7 quarters.
  • Exchange Traded Concepts's Repare Therapeutics position peaked at $257K in Q1 2024.
  • 50 funds tracked by Wall St. Rank held Repare Therapeutics as of Q1 2025.

Based on Exchange Traded Concepts's 13F filing for Q1 2025, filed 17 Apr 2025.